Acurx Pharmaceuticals Inc (ACXP)
2.04
+0.10
(+5.15%)
USD |
NASDAQ |
May 09, 16:00
2.02
-0.02
(-0.98%)
After-Hours: 20:00
Acurx Pharmaceuticals Shareholders Equity (Quarterly): 57.89M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.89M |
| September 30, 2023 | 3.935M |
| June 30, 2023 | 6.216M |
| March 31, 2023 | 5.311M |
| December 31, 2022 | 45.96M |
| September 30, 2022 | 9.763M |
| June 30, 2022 | 8.785M |
| Date | Value |
|---|---|
| March 31, 2022 | 10.69M |
| December 31, 2021 | 12.41M |
| September 30, 2021 | 14.28M |
| June 30, 2021 | 15.52M |
| March 31, 2021 | 2.471M |
| December 31, 2020 | 2.702M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.471M
Minimum
Mar 2021
57.89M
Maximum
Dec 2023
15.07M
Average
9.763M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| Seelos Therapeutics Inc | -33.51M |
| PetVivo Holdings Inc | 0.8951M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.709M |
| Total Liabilities (Quarterly) | 3.042M |